The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease
Open accessAbstract
Background & aims Non-alcoholic fatty liver disease is a common cause of chronic liver disease. Celiac disease alters intestinal permeability and treatment with a gluten-free diet often causes weight gain, but so far there are few reports of non-alcoholic fatty liver disease in patients with celiac disease.Methods Population-based cohort study. We compared the risk of non-alcoholic fatty liver disease diagnosed from 1997 to 2009 in individuals with celiac disease (n = 26,816) to matched reference individuals (n = 130,051). Patients with any liver disease prior to celiac disease were excluded, as were individuals with a lifetime diagnosis of alcohol-related disorder to minimize misclassification of non-alcoholic fatty liver disease. Cox regression estimated hazard ratios for non-alcoholic fatty liver disease were determined.Results During 246,559 person-years of follow-up, 53 individuals with celiac disease had a diagnosis of non-alcoholic fatty liver disease (21/100,000 person-years). In comparison, we identified 85 reference individuals diagnosed with non-alcoholic fatty liver disease during 1,488,413 person-years (6/100,000 person-years). This corresponded to a hazard ratio of 2.8 (95% CI 2.0-3.8), with the highest risk estimates seen in children (HR = 4.6; 95% CI 2.3-9.1). The risk increase in the first year after celiac disease diagnosis was 13.3 (95% CI 3.5-50.3) but remained significantly elevated even beyond 15 years after the diagnosis of celiac disease (HR = 2.5; 95% CI 1.0-5.9).Conclusion Individuals with celiac disease are at increased risk of non-alcoholic fatty liver disease compared to the general population. Excess risks were highest in the first year after celiac disease diagnosis, but persisted through 15 years after diagnosis with celiac disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been also shown that individuals with celiac disease, characterized by increased gut permeability, are at increased risk of NAFLD compared to the general population [296,297].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [297]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Self-citationSteatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
Ludvigsson, J. F., Otterblad-Olausson, P., Pettersson, B. U., & Ekbom, A. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9350-y · Cited by 2,437
Self-citationPowell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 836
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M. R., Kerwar, S. S., Torranee, D. S., Otten-Evans, C., Greenstreet, T. A., Weerawarna, K., et al. (1994) · Nature · doi:10.1038/370218a0 · Cited by 588
Health at a Glance: Europe 2010
OECD, & Union, E. (2010) · Health at a glance. Europe · doi:10.1787/health_glance-2010-en · Cited by 535
Research works printed but not linked: 1
- Carjsö K SB, Spetz CL. Evaluation of the Data quality in the Swedish National Hospital Discharge Register. Book Evaluation of the Data quality in the Swedish National Hospital Discharge Register (Editor eds.) City: WHO/HST/ICD/C/98.34; 1998. pp. 1–10.
Cited by
Sorted by citations
Celiac disease: a comprehensive current review
Caio, G., Volta, U., Sapone, A., Leffler, D. A., GIORGIO, R. D., Catassi, C., & Fasano, A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1380-z · Cited by 1,114
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
ESPEN practical guideline: clinical nutrition in liver disease
Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Plauth, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.001 · Cited by 383
Therrien, A., Kelly, C. P., & Silvester, J. A. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001267 · Cited by 176
Raiteri, A., Granito, A., Giamperoli, A., Catenaro, T., Negrini, G., & Tovoli, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i1.154 · Cited by 150
Diagnosis and management of secondary causes of steatohepatitis
Liebe, R., Esposito, I., Bock, H. H., Dahl, S. V., Stindt, J., Baumann, U., Luedde, T., & Keitel, V. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.045 · Cited by 114
Guidelines for best practices in monitoring established coeliac disease in adult patients
Elli, L., Leffler, D. A., Cellier, C., Lebwohl, B., Ciacci, C., Schümann, M., Lundin, K. E. A., Zammit, S. C., Sidhu, R., Roncoroni, L., et al. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00872-2 · Cited by 115
Self-citationRecent strategies for tackling the problems in gluten-free diet and products
Demirkesen, İ., & Özkaya, B. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1823814 · Cited by 98
Almeida, N. E. C., Vanga, R. R., Theethira, T. G., Rubio‐Tapia, A., Murray, J. A., Villafuerte-Gálvez, J., Bonder, A., Mukherjee, R., Hansen, J., Dennis, M. D., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.192 · Cited by 81
Tovoli, F., Negrini, G., Farì, R., Guidetti, E., Faggiano, C., Napoli, L., Bolondi, L., & Granito, A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14910 · Cited by 79
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Liver involvement in pediatric celiac disease
Anania, C., Luca, E. D., Castro, G. D., Chiesa, C., & Pacifico, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5813 · Cited by 66
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Agarwal, A. K., Singh, A., Mehtab, W., Gupta, V., Chauhan, A. K., Rajput, M. S., Singh, N., Ahuja, V., & Makharia, G. K. (2020) · Intestinal Research · doi:10.5217/ir.2019.00136 · Cited by 65
Marciano, F., Savoia, M., & Vajro, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.013 · Cited by 65
Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications
Hoffmanová, I., Sánchez, D., Tučková, L., & Tlaskalová‐Hogenová, H. (2018) · Nutrients · doi:10.3390/nu10070892 · Cited by 65
Review article: Follow‐up of coeliac disease
Tye–Din, J. A. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16847 · Cited by 61
Nakatsuka, A., Matsuyama, M., Yamaguchi, S., Katayama, A., Eguchi, J., Murakami, K., Teshigawara, S., Ogawa, D., Wada, N., Yasunaka, T., et al. (2016) · Scientific Reports · doi:10.1038/srep21721 · Cited by 58
Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders
Valvano, M., Longo, S. A., Stefanelli, G., Frieri, G., Viscido, A., & Latella, G. (2020) · Nutrients · doi:10.3390/nu12040940 · Cited by 56
Sourdough bread: A contemporary cereal fermented product
Sakandar, H. A., Hussain, R., Kubow, S. J., Sadiq, F. A., Huang, W., & Imran, M. (2019) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.13883 · Cited by 72
Felber, J., Schümann, M., Bläker, H., Fischbach, W., Koletzko, S., Laass, M. W., Lachmann, N., Lorenz, P., Lynen, P., Reese, I., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1741-5946 · Cited by 54
Rubio‐Tapia, A., & Murray, J. A. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.12.001 · Cited by 52
Sen, P., Carlsson, C., Virtanen, S. M., Simell, S., Hyöty, H., Ilonen, J., Toppari, J., Veijola, R., Hyötyläinen, T., Knip, M., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000044 · Cited by 48
Cardiometabolic risk factors in children with celiac disease on a gluten-free diet
Anania, C., Pacifico, L., Olivero, F., Perla, F. M., & Chiesa, C. (2017) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v6.i3.143 · Cited by 44
Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging
Koch, L. K., & Yeh, M. M. (2018) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2018.09.009 · Cited by 47
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
Chen, Y., & Yeh, M. M. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.07.006 · Cited by 39
Pediatric Nonalcoholic Fatty Liver Disease
Nobili, V., & Socha, P. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001823 · Cited by 36
Adams, L. C., Lübbe, F., Bressem, K. K., Wagner, M., Hamm, B., & Makowski, M. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206450 · Cited by 36
Celiac Disease and Elevated Liver Enzymes: A Review
Kim, J. V., & Wu, G. Y. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00089 · Cited by 37
Yuan, S., Jiang, F., Chen, J., Lebwohl, B., Green, P. H. R., Leffler, D. A., Larsson, S. C., Li, X., & Ludvigsson, J. F. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105033 · Cited by 34
Self-citationTINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35
Laszkowska, M., Mahadev, S., Sundström, J., Lebwohl, B., Green, P. H. R., Michaëlsson, K., & Ludvigsson, J. F. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14911 · Cited by 35
Self-citationNon-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
Piacentini, M., Baiocchini, A., Nonno, F. D., Melino, G., Barlev, N. A., Rossin, F., D’Eletto, M., & Falasca, L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0292-8 · Cited by 32
Celiac Disease and Its Role in the Development of Metabolic Bone Disease
Micić, D., Rao, V. L., & Semrad, C. E. (2019) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2019.06.005 · Cited by 34
Coeliac disease and invasive pneumococcal disease: a population-based cohort study
Tjernberg, A. R., Bonnedahl, J., Inghammar, M., Egesten, A., Kahlmeter, G., Nauclér, P., Henriques‐Normark, B., & Ludvigsson, J. F. (2017) · Epidemiology and Infection · doi:10.1017/s0950268816003204 · Cited by 27
Self-citationAlternative Etiologies of Liver Disease in Children With Suspected NAFLD
Yodoshi, T., Orkin, S. H., Arce‐Clachar, A. C., Bramlage, K., Xanthakos, S. A., Valentino, P. L., & Mouzaki, M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-009829 · Cited by 27
Laszkowska, M., Roy, A., Lebwohl, B., Green, P. H. R., Sundelin, H. E. K., & Ludvigsson, J. F. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.019 · Cited by 24
Self-citationTo screen or not to screen? Celiac antibodies in liver diseases
Narciso-Schiavon, J. L., & Schiavon, L. D. L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i5.776 · Cited by 24
Rinninella, E., Cintoni, M., Raoul, P. C., Triarico, S., Dionisi, T., Gasbarrini, G. B., Gasbarrini, A., & Mele, M. C. (2021) · Gastroenterology Insights · doi:10.3390/gastroent12020015 · Cited by 20
Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods
Raiteri, A., Granito, A., Faggiano, C., Giamperoli, A., Catenaro, T., Negrini, G., & Tovoli, F. (2022) · Nutrients · doi:10.3390/nu14142942 · Cited by 20
Celiac disease - a pluripathological model in pediatric practice
Lupu, V. V., Săsăran, M. O., Jechel, E., Stârcea, I. M., Ioniuc, I. K., Mocanu, A., Rosu, S. T., Münteanu, V., Nedelcu, A. H., Danielescu, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390755 · Cited by 19
Coeliac disease: complications and comorbidities
Ludvigsson, J. F., Yao, J., Lebwohl, B., Green, P. H. R., Yuan, S., & Leffler, D. A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01032-w · Cited by 24
Self-citationCeliac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
Cazac, G.-D., Mihai, B. M., Ștefănescu, G., Gîlcă-Blanariu, G.-E., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Lăcătușu, C.-M. (2024) · Nutrients · doi:10.3390/nu16132008 · Cited by 18
The use of peripheral blood mononuclear cells in celiac disease diagnosis and treatment
Kurki, A., Kemppainen, E., Laurikka, P., Kaukinen, K., & Lindfors, K. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1850262 · Cited by 18
Advances in the pathophysiology, diagnosis, and management of celiac disease
Doyle, J. B., Silvester, J. A., Ludvigsson, J. F., & Lebwohl, B. (2025) · BMJ · doi:10.1136/bmj-2024-081353 · Cited by 19
Self-citationHepatobiliary phenotype of individuals with chronic intestinal disorders
Voss, J., Schneider, C. V., Kleinjans, M., Bruns, T., Trautwein, C., & Strnad, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-98843-7 · Cited by 17
Kamal, S. M., Aldossari, K. K., Ghoraba, D., Abdelhakam, S. M., Kamal, A. H., Bedewi, M. A., Nabegh, L., Bahnasy, K., & Hafez, T. A. (2018) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000150 · Cited by 16
MAFLD and Celiac Disease in Children
Scapaticci, S., Venanzi, A., Chiarelli, F., & Giannini, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021764 · Cited by 37
Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction
Gaber, Y., AbdAllah, M., Salama, A., Sayed, M. M., Alem, S. A., & Nafady, S. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1952867 · Cited by 12
Mortality and causes of death in different celiac disease phenotypes during long-term follow-up
Koskinen, I., Hervonen, K., Huhtala, H., Pasternack, C., Salmi, T. T., Reunala, T. L., Collin, P., & Kaukinen, K. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.04.016 · Cited by 12
Extraintestinal complications of celiac disease: treatment considerations
Lazzano, P., Fracas, E., Nandi, N., Scaramella, L., & Elli, L. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2443053 · Cited by 11
Influence of genetically predicted autoimmune diseases on NAFLD
Xu, M., Wu, T., Li, Z., & Xin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229570 · Cited by 10
Amrousy, D. M. E., El-Shehaby, W. A., Elsharaby, R. M., Badr, S., Hamza, M. B., & Elbarky, A. M. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05343-z · Cited by 10
Nijhawan, S., & Goyal, G. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000350 · Cited by 9
Intestinal injury in the rat model of 17α‐ethynylestradiol‐induced intrahepatic cholestasis
Chang, M., Xu, Y., He, W., Zhang, C. L., Li, X. P., & Liu, D. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12407 · Cited by 7
Challenges to drug discovery for celiac disease and approaches to overcome them
Vaquero, L. M., Bernardo, D., León, F., Rodríguez‐Martín, L., Álvarez-Cuenllas, B., & Vivas, S. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1642321 · Cited by 8
Yuan, S., Leffler, D., Lebwohl, B., Green, P. H. R., Sun, J., Carlsson, S., Larsson, S. C., & Ludvigsson, J. F. (2024) · Diabetologia · doi:10.1007/s00125-024-06175-8 · Cited by 7
Self-citationFatty liver and celiac disease: Why worry?
Narciso-Schiavon, J. L., & Schiavon, L. D. L. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i5.666 · Cited by 7
Küçükseymen, S., Çekın, A. H., Bayar, N., Arslan, Ş., Uygur-Kucukseymen, E., Mercan, T., & Özdemir, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190382 · Cited by 7
Machado, M. V. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.90 · Cited by 7
A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
Manka, P. P., Sydor, S., Schänzer, J., Brandenburg, M., Best, J., Vilchez‐Vargas, R., Link, A., Heider, D., Brodesser, S., Figge, A., et al. (2022) · Metabolites · doi:10.3390/metabo12020130 · Cited by 7
Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease
Hitawala, A. A., Almomani, A., Onwuzo, S., Boustany, A., Kumar, P., & Asaad, I. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002599 · Cited by 7
Seidita, A., Latteri, F., Pistone, M., Giuliano, A., Bertoncello, L., Cavallo, G., Chiavetta, M., Faraci, F., Nigro, A., Termini, A., et al. (2024) · Nutrients · doi:10.3390/nu17010085 · Cited by 6
Yao, J., Sun, J., Ebrahimi, F., Bergman, D., Green, P. H. R., Hagström, H., Lebwohl, B., Leffler, D. A., & Ludvigsson, J. F. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101201 · Cited by 6
Self-citationCardiovascular risk factors in coeliac disease (ARCTIC): a protocol of multicentre series of studies
Vereczkei, Z., Imrei, M., Szakács, Z., Kővári, B., Papp, V., Lénárt, Z., Berki, T., Szirmay, B., Farkas, N., Balaskó, M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068989 · Cited by 5
Mediterranean Diet Adherence in Celiac Patients: A Nested Cross-Sectional Study
Peresztegi, M. Z., Szakács, Z., Vereczkei, Z., Dakó, E., Dakó, S., Lada, S., Lemes, K., Holczer, M., Farkas, N., & Bajor, J. (2025) · Nutrients · doi:10.3390/nu17050788 · Cited by 6
Hastier, A., Patouraux, S., Canivet, C. M., Lebeaupin, C., Tran, A., & Anty, R. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.09.006 · Cited by 5
Body Mass Index during Gluten-Free Diet in Patients with Celiac Disease
Vereczkei, Z., Dergez, T., Fodor, Z., Szakács, Z., & Bajor, J. (2023) · Nutrients · doi:10.3390/nu15163517 · Cited by 5
Intestinal gluconeogenesis is downregulated in pediatric patients with celiac disease
Karlson, O., Arnell, H., Gudjónsdóttir, A. H., Agardh, D., & Naluai, Å. T. (2022) · BMC Medicine · doi:10.1186/s12916-022-02635-3 · Cited by 4
Renno, A. W., Abdel‐Aziz, Y., Alastal, Y., Khuder, S., Hasan, S., Assaly, R., & Nawras, A. T. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.104488 · Cited by 4
Pei, J., Wei, S., Pei, Y., Wu, H., & Wang, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190409120716 · Cited by 3
Dikker, O., & Dağ, H. (2019) · Medical Principles and Practice · doi:10.1159/000503633 · Cited by 3
Penny, H. A., Shiha, M. G., Raju, S. A., Nandi, N., Trott, N., Batlle, C. C., Whelan, J., Schiepatti, A., Andrews, C., Preest, G., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337747 · Cited by 3
Self-citationNovel Insights to Celiac Disease: A review article
Pourtalebi-Firoozabadi, A., Mohamadian, M., Parsamanesh, N., Moossavi, M., & Naseri, M. (2016) · Research in Molecular Medicine · doi:10.18869/acadpub.rmm.4.2.1 · Cited by 2
Pitchumoni, C. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_69 · Cited by 2
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?
Tovoli, F., Faggiano, C., Raiteri, A., Giamperoli, A., Catenaro, T., Sansone, V., Pallotta, D. P., & Granito, A. (2022) · Nutrients · doi:10.3390/nu14061223 · Cited by 2
Schranz, M., Lucà, M. G., D’Antiga, L., & FAGIUOLI, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-96400-3_22 · Cited by 2
Cioni, G. (2018) · Polish Annals of Medicine · doi:10.29089/2017.17.00034 · Cited by 1
Cadenhead, J. W., Lee, A. R., Nguyen, T. T. T., Lebwohl, B., Green, P. H. R., & Wolf, R. L. (2024) · Nutrients · doi:10.3390/nu16183067 · Cited by 1
Self-citationTowards personalized microbial therapies for metabolic alterations in celiac disease
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100584 · Cited by 1
Forcina, G., Frattolillo, V., Cesare, M. D., Floriano, A., Palma, R., Casamassima, F., Bartiromo, M., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2600386 · Cited by 1
Kaushalya, S. D. N., Wijesinghe, W. A. J. P., & Kim, E. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr38564 · Cited by 1
Marxer, C. A., Ebrahimi, F., Bergman, D., Sun, J., Hagström, H., Thuresson, M., Stephansson, O., & Ludvigsson, J. F. (2026) · Scientific Reports · doi:10.1038/s41598-026-46246-x · Cited by 1
Self-citationÇÖLYAK HASTALIĞININ KARACİĞER TUTULUMLARI
Düzenli, T., & Tanoğlu, A. (2017) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.18017/iuitfd.363589 · Cited by 1
Celiac disease in Chilean adults
von Mühlenbrock, C., & Madrid-Silva, A. M. (2022) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2022.03.007 · Cited by 1
Assessment of Cardiac Functions in Children Suffering from Celiac Disease
Aslan, A. E., El-Shehaby, W. A., Eldein, A. M. B., Elsharaby, R. M., & Elbarky, A. M. (2023) · Asian Journal of Pediatric Research · doi:10.9734/ajpr/2023/v13i2260 · Cited by 1
Letter: Breaking new ground—Understanding the role of ATI‐free diet in managing MASLD
Spertino, M., Rossi, R. E., & Pugliese, N. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18064 · Cited by 1
Celiac Disease and Metabolic Diseases: A Review of Emerging Connections
Reidy, D., Cao, C., Rosenstock, A., Stoffels, M., Kumar, S. R., & Zylberberg, H. M. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00471-x · Cited by 1
Non-dietary therapies for celiac disease
Yoosuf, S., Therrien, A., & Leffler, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821571-5.00011-8 · Cited by 1
Case 27-2023: A 53-Year-Old Woman with Celiac Disease and Upper Gastrointestinal Bleeding
Hashemi, N., Lopes, E. W., Dhami, R. S., Lin, A. E., & Moodley, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmcpc2300903 · Cited by 1
Managing individuals with non-immune food hypersensitivity
Skypala, I. J., & Reese, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00129-2 · Cited by 1
Fontanella, A., Nardi, R., Masina, M., & Uomo, G. (2017) · Italian Journal of Medicine · doi:10.4081/itjm.q.2017.7
Non alcoholic fatty liver disease in a young male with celiac disease
Majid, Z., Somoro, G. B., Haque, M. M. U., Yaseen, R. T., Khan, S. A., Achakzai, I. K., Khalid, M. A., & Luck, N. H. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.25.16345
Bischoff, S. C., Bernal, W. E., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., Plauth, M., Скрипник, І. М., & Shvets, O. (2021) · Modern Gastroenterology · doi:10.30978/mg-2021-1-59
INTESTINAL GLUCONEOGENESIS IS DOWNREGULATED IN PAEDIATRIC PATIENTS WITH COELIAC DISEASEPreprint
Karlson, O., Arnell, H., Gudjónsdóttir, A. H., Agardh, D., & Naluai, Å. T. (2021) · medRxiv · doi:10.1101/2021.09.08.21262795
Holmes, G. K. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821846-4.00004-8
Pitchumoni, C. S. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_69-1
Enfermedad celiaca en adultos chilenos
von Mühlenbrock, C., & Madrid-Silva, A. M. (2022) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2021.04.009
Patel, P., & Micić, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-94953-2_6
Research Progress on Inflammatory Bowel Disease Complicated with Non-Alcoholic Fatty Liver Disease
马, 有. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361327
Nonalcoholic Fatty Liver Disease Within Other Causes of Chronic Liver Diseases
Gheorghe, L. S., & Iacob, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_12
Metadata
- Authors
- Reilly, N. R., Lebwohl, B., Hultcrantz, R., Green, P. H. R., & Ludvigsson, J. F.
- Affiliations
- Columbia University Irving Medical Center (US)
- Karolinska Institutet (SE)
- Örebro University (SE)
- Corresponding author
- Ludvigsson, Jonas F.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 62
- Issue
- 6
- Pages
- 1405-1411
- ISSN
- 0168-8278 (ISSN-L)
- PMC
- PMC4439270
- OpenAlex
- W2089313045
- Cited by
- 110
- References
- 44
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 12 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 7 · 2016: 4 · 2015: 5
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000040, KL2TR001874)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, celiac disease, gluten-free diet, intestinal permeability, weight gain, chronic liver disease, children
- MeSH terms
- Adolescent, Adult, Aged, Celiac Disease, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Middle Aged, Risk Factors, Sweden, Time Factors, Cohort Studies, Young Adult, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
